Vertex Pharmaceuticals Inc. buy Citigroup Inc.
Start price
02.10.25
/
50%
€346.50
Target price
02.10.26
€489.84
Performance (%)
12.38%
Price
23.12.25
€389.40
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ currently has a performance of 12.38%. This prediction currently runs until 02.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -0.064% | -0.064% |
| iShares Core DAX® | 0.224% | 2.031% |
| iShares Nasdaq 100 | 0.371% | -0.955% |
| iShares Nikkei 225® | 0.972% | -0.953% |
| iShares S&P 500 | 0.417% | -0.622% |
Comments by Citigroup_Inc_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target raised by analysts at Citigroup Inc. from $550.00 to $575.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€470.80
14.11.24
14.11.24
€545.96
14.11.25
14.11.25
-19.47%
15.11.25
15.11.25
